# ovariancancer cancersucks nonhodgkinslymphoma naturalkillercells naturalkillercellsforcancer trial clinicaltrials neuromuscular australian brainstimulation ocd universityofqueensland science newspaper test cysticfibrosis covid19 pneumonia lungcancer lungmatrix lcam whywedoresearch psychedelic webinar mdma psilocybin education mentalhealth vacancy medicalscience jobs

It’s a myth that patients are not told about the risks of a before choosing to participate. Visit https://t.co/CwUEwTW5RD to learn more about clinical trials and how they can help patients. Please share to raise awareness.

16 23
2023-04-04

Hospital wants me to come back for a 3rd cycle of treatment. Not because of cancer progression, but because of how good my initial results were. So back to Houston! Let’s do this!

0 0
2022-10-06

Follow us on our journey as we begin to set up this exciting new

1 3
2022-03-30

Have you met the Lab's Clinical Team?

📋The team helps run and support the lab’s clinical work including: adult and pediatric trials, patient registries, and natural history studies.

Read more: https://t.co/YVj2oWV56y

1 4
2021-07-29

Artdaily recommends:
Australian-first clinical trial shows brain stimulation can treat severe OCD The University of Queensland

Read more about this here: https://t.co/GrBrv97lE7

0 2
2021-04-23

When women's physiology isn't studied with the same intensity as mens, crucial information about differences in metabolism may be overlooked. Read more here: https://t.co/c4KFoTf9af

3 5
2021-03-31

ArtDaily recommends:
Clinical trial to test cystic fibrosis drug for severe COVID-19 pneumonia https://t.co/mBXesF1SNl

0 1
2020-08-09

November is awareness month: Discover how researchers are addressing non-small cell lung cancer (the most common type), by looking at each individual patients' gene changes: https://t.co/gfdjT7JZws

4 2
2018-11-19

On the first day of awareness month, learn how researchers are addressing non-small cell lung cancer (the most common type), by looking at each individual patients' gene changes:
https://t.co/MhYQxynGHC

5 2
2018-11-02